Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Long-Term Debt Repayments (2021)

Maxcyte (MXCT) has disclosed Long-Term Debt Repayments for 1 consecutive years, with $4.9 million as the latest value for Q1 2021.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $4.9 million in Q1 2021 year-over-year; TTM through Dec 2021 was $4.9 million, a N/A change, with the full-year FY2021 number at $4.9 million, up 241.83% from a year prior.
  • Long-Term Debt Repayments was $4.9 million for Q1 2021 at Maxcyte.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $4.9 million in Q1 2021 to a low of $4.9 million in Q1 2021.